These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23466634)

  • 1. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
    Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
    Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
    Althurwi HN; Tse MM; Abdelhamid G; Zordoky BN; Hammock BD; El-Kadi AO
    Br J Pharmacol; 2013 Apr; 168(8):1794-807. PubMed ID: 23176298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
    Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
    Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
    Zordoky BN; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
    Althurwi HN; Elshenawy OH; El-Kadi AO
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):167-77. PubMed ID: 24157956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
    Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
    Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
    J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.
    Maayah ZH; Abdelhamid G; El-Kadi AO
    Cell Biol Toxicol; 2015 Oct; 31(4-5):241-59. PubMed ID: 26493311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
    Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
    Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism.
    Zordoky BN; El-Kadi AO
    Toxicol In Vitro; 2010 Apr; 24(3):863-71. PubMed ID: 19969063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
    Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
    Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Shoieb SM; El-Kadi AOS
    Drug Metab Dispos; 2018 Aug; 46(8):1157-1168. PubMed ID: 29880629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.
    Zordoky BN; El-Kadi AO
    Vascul Pharmacol; 2008; 49(4-6):166-72. PubMed ID: 18707023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene.
    Aboutabl ME; Zordoky BN; Hammock BD; El-Kadi AO
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):273-81. PubMed ID: 21383588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, β-MHC) in rat cardiomyocyte H9c2 cells.
    Alsaad AMS
    Toxicol Mech Methods; 2018 Nov; 28(9):678-684. PubMed ID: 29975149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
    Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
    J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
    Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
    Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
    Elkhatali S; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; El-Kadi AO
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):550-9. PubMed ID: 26454030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.